Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons
暂无分享,去创建一个
Luigi F Agnati | Sergi Ferré | Rafael Franco | K. Fuxe | L. Agnati | C. Lluis | R. Franco | S. Ferré | Kjell Fuxe | Carme Lluis
[1] M. Caron,et al. Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.
[2] K. Fuxe,et al. Evidence for Adenosine/Dopamine Receptor Interactions: Indications for Heteromerization , 2000, Neuropsychopharmacology.
[3] Robert J. Lefkowitz,et al. Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors , 2001, Nature Reviews Neuroscience.
[4] K. Fuxe,et al. Evidence for Cholecystokinin‐Dopamine Receptor Interactions in the Central Nervous System of the Adult and Old Rat , 1985, Annals of the New York Academy of Sciences.
[5] G. Koob. The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction , 1999, Annals of the New York Academy of Sciences.
[6] N. Bowery,et al. GABAB receptors: drugs meet clones , 1998, Current Opinion in Neurobiology.
[7] K. Fuxe,et al. Autoradiographic evidence for a bradykinin/angiotensin II receptor-receptor interaction in the rat brain , 1993, Neuroscience Letters.
[8] F. Ciruela,et al. Adenosine A 2 B Receptors Behave as an Alternative Anchoring Protein for Cell Surface Adenosine Deaminase in Lymphocytes and Cultured Cells , 2000 .
[9] P. Hedlund,et al. Effects of adenosine A2A receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain , 1999 .
[10] S. Sesack,et al. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum , 1997, Brain Research.
[11] D. Linden,et al. Homer Binds a Novel Proline-Rich Motif and Links Group 1 Metabotropic Glutamate Receptors with IP3 Receptors , 1998, Neuron.
[12] G. Robertson,et al. D1 and D2 dopamine receptors differentially increase fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain , 1995, Neuroscience.
[13] K. Fuxe,et al. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A2A and dopamine D2 receptors , 2002, Neuroscience Letters.
[14] K. Fuxe,et al. Postsynaptic antagonistic interaction between adenosine A1, and dopamine D1 receptors , 1994, Neuroreport.
[15] D. Malec. Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists. , 1997, Polish journal of pharmacology.
[16] M. Morelli,et al. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors , 2000, Behavioural Brain Research.
[17] R. Lefkowitz,et al. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. , 2001, Current opinion in cell biology.
[18] Garrett E. Alexander. Basal ganglia , 1998 .
[19] J. Vincent,et al. Reduction of dopamine D2 receptor transduction by activation of adenosine A2a receptors in stablyA2a/D2 (long-form) receptor co-transfected mouse fibroblast cell lines: Studies on intracellular calcium levels , 1995, Neuroscience.
[20] R. Duvoisin,et al. The metabotropic glutamate receptors: Structure and functions , 1995, Neuropharmacology.
[21] S. Coughlin,et al. PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.
[22] J. Wierońska,et al. Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats , 2001, Neuropharmacology.
[23] A. Kastin,et al. CNS effects of somatostatin. , 1978, Metabolism: clinical and experimental.
[24] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[25] R. Roth,et al. The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia , 1999, Neuropsychopharmacology.
[26] R. Andrew,et al. ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. , 2000, The Journal of pharmacology and experimental therapeutics.
[27] M. Dragunow,et al. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. , 1995, Pharmacological reviews.
[28] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[29] M. Zarbin,et al. Axonal transport of muscarinic cholinergic receptors in rat vagus nerve: high and low affinity agonist receptors move in opposite directions and differ in nucleotide sensitivity , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] F. Ciruela,et al. Immunological identification of A1 adenosine receptors in brain cortex , 1995, Journal of neuroscience research.
[31] N. Zahniser,et al. Modulation of endogenous GABA release by an antagonistic adenosine A1 / dopamine D1 receptor interaction in rat brain limbic regions but not basal ganglia , 1999, Synapse.
[32] M. Low,et al. Functional Uncoupling of Adenosine A2A Receptors and Reduced Response to Caffeine in Mice Lacking Dopamine D2Receptors , 2000, The Journal of Neuroscience.
[33] S. Coughlin,et al. PAR 3 is a cofactor for PAR 4 activation by thrombin , 2022 .
[34] W. Hauber,et al. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A2A receptors in the caudate‐putamen of rats , 2001, The European journal of neuroscience.
[35] T. Shindou,et al. The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] J. Gutkind,et al. Gα12- and Gα13-Subunits of Heterotrimeric G-Proteins A Novel Family of Oncogenes , 1998 .
[37] P J Richardson,et al. Desensitisation of the Adenosine A1 Receptor by the A2A Receptor in the Rat Striatum , 1997, Journal of neurochemistry.
[38] H. Lother,et al. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.
[39] F. Marshall,et al. GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.
[40] Charles J. Wilson,et al. Chapter II The basal ganglia , 1996 .
[41] K. Fuxe,et al. l-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes. , 1984, European journal of pharmacology.
[42] Carey J. Denholm. 2000 and Beyond , 1990 .
[43] Robert J. Lefkowitz,et al. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Fuxe,et al. Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and alpha 2-adrenoceptors. , 1989, European journal of pharmacology.
[45] M. Sheng,et al. The Shank family of scaffold proteins. , 2000, Journal of cell science.
[46] R. Lefkowitz,et al. Beta-Arrestins: new roles in regulating heptahelical receptors' functions. , 2001, Cellular signalling.
[47] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[48] B. Bloch,et al. D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.
[49] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[50] S. Hyman,et al. Proenkephalin gene regulation in the neuroendocrine hypothalamus: a model of gene regulation in the CNS. , 1995, The American journal of physiology.
[51] P. Greengard,et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine , 2002, Nature.
[52] P. Goldman-Rakic,et al. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. , 2000, Science.
[53] K. Fuxe,et al. Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat , 1991, Brain Research.
[54] R. Lefkowitz,et al. Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes. , 1976, The Journal of biological chemistry.
[55] H. Friesen,et al. Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system , 1976, Pharmacology Biochemistry and Behavior.
[56] Jean-Charles Sanchez,et al. Proteomics: new perspectives, new biomedical opportunities , 2000, The Lancet.
[57] K. Fuxe,et al. Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites. , 1983, Acta physiologica Scandinavica.
[58] E. Richelson,et al. Characterization of the Genomic Structure, Promoter Region, and a Tetranucleotide Repeat Polymorphism of the Human Neurotensin Receptor Gene* , 1997, The Journal of Biological Chemistry.
[59] T. Hökfelt,et al. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. , 1981, Acta physiologica Scandinavica.
[60] S. Fenu,et al. Motor stimulant effects of caffeine in 6‐hydroxydopamine‐lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors , 1998, The European journal of neuroscience.
[61] P. Barnes,et al. Effects of adenosine on autonomic control of heart rate in man. , 1987, Acta physiologica Scandinavica.
[62] Shigetada Nakanishi,et al. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain , 1993, Neuroscience Letters.
[63] K. Fuxe,et al. Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia , 1992, Neurochemistry International.
[64] S. Latini,et al. Adenosine in the central nervous system: release mechanisms and extracellular concentrations , 2001, Journal of neurochemistry.
[65] J. F. Chen,et al. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] J. Changeux,et al. Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors , 2001, Current Opinion in Neurobiology.
[67] K. Fuxe,et al. Adenosine A1 Receptor-mediated Modulation of Dopamine D1 Receptors in Stably Cotransfected Fibroblast Cells* , 1998, The Journal of Biological Chemistry.
[68] B B Fredholm,et al. Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells. , 1996, European journal of pharmacology.
[69] K. Fuxe,et al. The Selective mGlu5 Receptor Agonist CHPG Inhibits Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats and Modulates the Binding Characteristics of Dopamine D2 Receptors in the Rat Striatum Interactions with Adenosine A2a Receptors , 2001, Neuropsychopharmacology.
[70] J. Venter,et al. The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. , 1982, Biochemical and biophysical research communications.
[71] J. Mallol,et al. Solubilization of A1 adenosine receptor from pig brain: Characterization and evidence of the role of the cell membrane on the coexistence of high‐ and low‐affinity states , 1990, Journal of neuroscience research.
[72] P. Svenningsson,et al. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons , 1999, Neuroscience.
[73] U. Ungerstedt,et al. Receptor‐Receptor Interactions and Their Relevance for Receptor Diversity , 1995, Annals of the New York Academy of Sciences.
[74] K. Fuxe,et al. Reduction of [3H]nicotine binding by clonidine in membrane preparations of the rat cerebral cortex. , 1988, Acta physiologica Scandinavica.
[75] F E Cohen,et al. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. , 1998, Science.
[76] P. d'Alcantara,et al. Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission , 2001, Neuroscience.
[77] K. Fuxe,et al. Galanin/5-HT interactions in the rat central nervous system. Relevance for depression , 1991 .
[78] Lakshmi A Devi,et al. Opioids and Their Complicated Receptor Complexes , 2000, Neuropsychopharmacology.
[79] K. Fuxe,et al. Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum. , 1993, European journal of pharmacology.
[80] Molly M. Huntsman,et al. Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics , 1998 .
[81] T. Duke,et al. Heightened sensitivity of a lattice of membrane receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[82] J Engel,et al. Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. , 1999, Biochemistry.
[83] T. Bártfai,et al. Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland , 1982, Nature.
[84] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[85] F. Ciruela,et al. Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. , 2001, Molecular pharmacology.
[86] S. Ferré,et al. Adenosine as a volume transmission signal. A feedback detector of neuronal activation. , 2000, Progress in brain research.
[87] P. Goldman-Rakic,et al. Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.
[88] Kenneth A. Jones,et al. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.
[89] S. Ferré,et al. GABA-Dopamine Receptor-Receptor Interactions in Neostriatal Membranes of the Rat , 1997, Neurochemical Research.
[90] K. Beaumont,et al. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors. , 1997, Molecular pharmacology.
[91] C. Heldin,et al. Dimerization of cell surface receptors in signal transduction , 1995, Cell.
[92] B. E. Garrett,et al. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction. , 1994, European journal of pharmacology.
[93] R. Iyengar,et al. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor. , 1984, The Journal of biological chemistry.
[94] M. Hollenberg. Structure‐activity relationships for transmembrane signaling: the receptor's turn , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[95] K. Fuxe,et al. Selective modulation of the NPY receptors of the Y2 subtype by α2 receptors in the nucleus tractus solitarii of the rat. A cardiovascular and quantitative receptor autoradiographical analysis , 1994, Brain Research.
[96] S. Gauthier,et al. Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates , 1988, Neurology.
[97] B B Fredholm,et al. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. , 1995, Pharmacology & toxicology.
[98] B. McEwen,et al. Modulation by vasoactive intestinal peptide of serotonin1 receptors in the dorsal hippocampus of the rat brain: An autoradiographic study , 1983, Neuroscience Letters.
[99] K. Fuxe,et al. Adenosine-dopamine interactions in the brain , 1992, Neuroscience.
[100] P. Svenningsson,et al. Distribution, biochemistry and function of striatal adenosine A2A receptors , 1999, Progress in Neurobiology.
[101] R. Corbett,et al. Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. , 1996, European journal of pharmacology.
[102] A. Hanyaloglu,et al. Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.
[103] K. Fuxe,et al. Receptor-Receptor Interactions , 1987, Wenner-Gren Center International Symposium Series.
[104] K. Fuxe,et al. Receptor-receptor interactions : a new intramembrane integrative mechanism : proceedings of an international symposium held at the Wenner-Gren Center, Stockholm, October 9th-11th, 1986 , 1987 .
[105] K. Fuxe,et al. Antagonistic regulation of α2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii , 1994 .
[106] A. Maiorana,et al. Insulin Resistance and Insulin-Like Growth Factors in Children with Intrauterine Growth Retardation , 2004, Hormone Research in Paediatrics.
[107] K. Fuxe,et al. Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes , 1993, Neuroscience Letters.
[108] S. Ferré,et al. Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-D-aspartate on motor activity in mice. , 1995, European journal of pharmacology.
[109] B. O'dowd,et al. Oligomerization of Dopamine and Serotonin Receptors , 2000, Neuropsychopharmacology.
[110] T. Kohout,et al. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[111] M. Morelli,et al. Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. , 2001, Synapse.
[112] C. Lluis,et al. Adenosine A(1) receptor in cultured neurons from rat cerebral cortex: colocalization with adenosine deaminase. , 2002, Journal of neurochemistry.
[113] P S Goldman-Rakic,et al. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[114] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[115] P. Seeman,et al. Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.
[116] K. Fuxe,et al. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors. , 1989, Acta physiologica Scandinavica.
[117] J. Kehr,et al. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum , 1999, Neuropharmacology.
[118] T Pawson,et al. SH2 domains, interaction modules and cellular wiring. , 2001, Trends in cell biology.
[119] T. Heffner,et al. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice , 2004, Psychopharmacology.
[120] K. Fuxe,et al. Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system , 1993, Neurochemistry International.
[121] P. Goldman-Rakic,et al. Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.
[122] K. Fuxe,et al. Evidence for interactions between [3H]glutamate and [3H]kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity , 1983, Neuroscience Letters.
[123] Sergi Ferré,et al. Antagonistic A2a/D2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system , 1993 .
[124] L F Agnati,et al. Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. , 2000, Progress in brain research.
[125] C. Romano,et al. Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.
[126] U. Ungerstedt,et al. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses , 2004, Psychopharmacology.
[127] S. Ögren. The Behavioural Pharmacology of Typical and Atypical Antipsychotic Drugs , 1996 .
[128] Pierre Corvol,et al. Polar Residues in the Transmembrane Domains of the Type 1 Angiotensin II Receptor Are Required for Binding and Coupling , 1996, The Journal of Biological Chemistry.
[129] K. Yamamoto,et al. Hold 'em and fold 'em: chaperones and signal transduction. , 1995, Science.
[130] R. Idzerda,et al. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[131] F. Ciruela,et al. Homer-1c/Vesl-1L Modulates the Cell Surface Targeting of Metabotropic Glutamate Receptor Type 1α: Evidence for an Anchoring Function , 2000, Molecular and Cellular Neuroscience.
[132] B. Parsons,et al. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats , 1993, Brain Research.
[133] L. Agnati,et al. Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs. , 1996, Brain research. Molecular brain research.
[134] A. Montecucco,et al. Potentiation of dopamine‐induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons , 1998, The European journal of neuroscience.
[135] F. Ciruela,et al. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. , 2001, Molecular pharmacology.
[136] J. Scott,et al. A-kinase anchoring proteins: protein kinase A and beyond. , 2000, Current opinion in cell biology.
[137] C. Lluis,et al. Enzymatic and extraenzymatic role of ecto‐adenosine deaminase in lymphocytes , 1998, Immunological reviews.
[138] K. Fuxe,et al. Differential Effects of lntrastriatal Neurotensin(1–13) and Neurotensin(8–13) on Striatal Dopamine and Pallidal GABA Release. A Dual‐probe Microdialysis Study in the Awake Rat , 1997, The European journal of neuroscience.
[139] A. D. Smith,et al. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy , 1995, Neuroscience.
[140] B B Fredholm,et al. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[141] Fraser Cm,et al. beta-Adrenergic receptor isolation and characterization with immobilized drugs and monoclonal antibodies. , 1983 .
[142] Rafael Franco,et al. Adenosine deaminase affects ligand‐induced signalling by interacting with cell surface adenosine receptors , 1996, FEBS letters.
[143] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[144] Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain. , 1991, Brain research.
[145] R. Lefkowitz,et al. Beta-adrenergic receptors: evidence for negative cooperativity. , 1975, Biochemical and biophysical research communications.
[146] T. Pawson,et al. Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.
[147] Iain D.C. Fraser,et al. Assembly of an A kinase-anchoring protein–β2-adrenergic receptor complex facilitates receptor phosphorylation and signaling , 2000, Current Biology.
[148] K. Fuxe,et al. Galanin and 5‐HT1A Receptor Interactions as an Integrative Mechanism in 5‐HT Neurotransmission in the Brain a , 1996, Annals of the New York Academy of Sciences.
[149] L. Devi,et al. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[150] U. Ungerstedt,et al. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. , 1974, Medical biology.
[151] U. Ungerstedt,et al. Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum , 1989, Brain Research.
[152] K. Neve,et al. Constitutive activity of a chimeric D2/D1 dopamine receptor. , 1997, Molecular pharmacology.
[153] J. Stewart,et al. Conversion of a gonadotropin-releasing hormone antagonist to an agonist , 1982, Nature.
[154] S. Snyder,et al. Adenosine as a neuromodulator. , 1985, Annual review of neuroscience.
[155] E. Rodríguez-Martín,et al. Dopamine enhances somatostatin receptor‐mediated inhibition of adenylate cyclase in rat striatum and hippocampus , 1997, Journal of neuroscience research.
[156] K. Fuxe,et al. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. , 1983, Journal of neural transmission. Supplementum.
[157] R. Mayfield,et al. Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: Evidence for an A2a/D2 receptor interaction in globus pallidus , 1996, Synapse.
[158] K. Fuxe,et al. Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum , 1992, Brain Research.
[159] D. Standaert,et al. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[160] K. Fuxe,et al. Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. , 2003, Journal of neural transmission. Supplementum.
[161] F. Ciruela,et al. Cell surface adenosine deaminase: Much more than an ectoenzyme , 1997, Progress in Neurobiology.
[162] M. Caron,et al. Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. , 1993, Biochemistry.
[163] M. Ochi,et al. Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats. , 2000, European journal of pharmacology.
[164] P. Jenner,et al. Combined Use of the Adenosine A2A Antagonist KW-6002 with l -DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys , 2000, Experimental Neurology.
[165] K. Fuxe,et al. Modulation of Dopamine D1 and D2 Transmission Lines in the Central Nervous System , 1990 .
[166] J. Penney,et al. Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons , 1995, The Journal of comparative neurology.
[167] H. Normile,et al. Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression , 1993, Brain Research Bulletin.
[168] D. Storm,et al. Making New Connections Role of ERK/MAP Kinase Signaling in Neuronal Plasticity , 1999, Neuron.
[169] R A Challiss,et al. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. , 2001, The Biochemical journal.
[170] J. Dickenson,et al. Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. , 2000, Molecular pharmacology.
[171] K. Fuxe,et al. Aspects of neural plasticity in the central nervous system—VII. Theoretical aspects of brain communication and computation , 1990, Neurochemistry International.
[172] M. Cohn,et al. ‘Barrel rotation’ induced by somatostatin in the non-lesioned rat , 1975, Brain Research.
[173] J. Knott. The organization of behavior: A neuropsychological theory , 1951 .
[174] P. Svenningsson,et al. Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum , 2000 .
[175] K. Fuxe,et al. Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic , 1997, Neuropsychopharmacology.
[176] F. Marshall. Heterodimerization of G-protein-coupled receptors in the CNS. , 2001, Current opinion in pharmacology.
[177] R. Caputto,et al. Neural transmission, learning, and memory , 1983 .
[178] Roger L Albin,et al. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons , 1998, Brain Research.
[179] K. Fuxe,et al. Galanin‐(1‐16) modulates 5‐HTIA receptors in the ventral limbic cortex of the rat , 2000, Neuroreport.
[180] E. Wilson,et al. Hormone-dependent Transactivation by the Human Androgen Receptor Is Regulated by a dnaJ Protein (*) , 1995, The Journal of Biological Chemistry.
[181] D. Dorsa,et al. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-HT4 or 5-HT6 receptors following antipsychotic administration , 1999, Neuroscience.
[182] M. Amalric,et al. Chronic But Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of Parkinsonism , 2002, The Journal of Neuroscience.
[183] K. Fuxe,et al. Antagonistic Oxytocin/α2‐Adrenoreceptor Interactions in the Nucleus Tractus Solitarii: Relevance for Central Cardiovascular Control , 2000, Journal of neuroendocrinology.
[184] A G Cochran,et al. Antagonists of protein-protein interactions. , 2000, Chemistry & biology.
[185] Michele Zoli,et al. Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors* , 2002, The Journal of Biological Chemistry.
[186] G. Milligan,et al. Protein-protein interactions at G-protein-coupled receptors. , 2001, Trends in pharmacological sciences.
[187] K. Fuxe,et al. Molecular Basis of Learning and Memory: Modelling Based on Receptor Mosaics , 2002 .
[188] A. Carlsson,et al. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.
[189] L. Grégoire,et al. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys , 1999, Neurology.
[190] M. Caporali,et al. Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility , 1991, The Journal of pharmacy and pharmacology.
[191] A. Spiegel. G Proteins, Receptors, and Disease , 1998, Contemporary Endocrinology.
[192] Kohjiro Ueki,et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone , 1997, Nature.
[193] K. Fuxe,et al. Intramembrane Interactions between Neurotensin Receptors and Dopamine D2 Receptors as a Major Mechanism for the Neuroleptic‐like Action of Neurotensin a , 1992, Annals of the New York Academy of Sciences.
[194] P. Greengard,et al. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms , 1999, Neuroscience.
[195] P. Jenner,et al. Alterations in preproenkephalin and adenosine‐2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l‐DOPA , 2000, The European journal of neuroscience.
[196] Y. Jan,et al. A Trafficking Checkpoint Controls GABAB Receptor Heterodimerization , 2000, Neuron.
[197] J. Glowinski,et al. Modulation by Monoamines of Somatostatin‐Sensitive Adenylate Cyclase on Neuronal and Glial Cells from the Mouse Brain in Primary Cultures , 1985, Journal of neurochemistry.
[198] P. Somogyi,et al. Immunocytochemical Localization of the α1 and β2/3 Subunits of the GABAA Receptor in Relation to Specific GABAergic Synapses in the Dentate Gyrus , 1995 .
[199] U. Ungerstedt,et al. Dopamine D1 Receptor‐mediated Facilitation of GABAergic Neurotransmission in the Rat Strioentopeduncular Pathway and its Modulation by Adenosine A1 Receptor‐mediated Mechanisms , 1996, The European journal of neuroscience.
[200] P. Goldman-Rakic,et al. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[201] K. Fuxe,et al. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat , 1991, Brain Research.
[202] F. Ciruela,et al. The cluster-arranged cooperative model: a model that accounts for the kinetics of binding to A1 adenosine receptors. , 1996, Biochemistry.
[203] B. Kieffer. Opioids: first lessons from knockout mice. , 1999, Trends in pharmacological sciences.
[204] O. Manzoni,et al. Decreased Presynaptic Sensitivity to Adenosine after Cocaine Withdrawal , 1998, The Journal of Neuroscience.
[205] R. Wallace. Dopamine D1 receptor , 1996 .
[206] K. Fuxe,et al. Aspects on the information handling by the central nervous system: focus on cotransmission in the aged rat brain. , 1986, Progress in brain research.
[207] K. Fuxe,et al. Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates , 2001, Peptides.
[208] P. Jenner,et al. Adenosine A2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys , 1998, Annals of neurology.
[209] P. Popoli,et al. Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats. , 1994, European journal of pharmacology.
[210] B. Borowsky,et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. , 1998, Nature.
[211] S. Grant,et al. Proteomics of multiprotein complexes: answering fundamental questions in neuroscience. , 2001, Trends in biotechnology.
[212] M. Mirabet,et al. Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. , 1999, Journal of cell science.
[213] Jilly F. Evans,et al. Identification of a GABAB Receptor Subunit, gb2, Required for Functional GABAB Receptor Activity* , 1999, The Journal of Biological Chemistry.
[214] L F Agnati,et al. Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum , 2001, Neuroreport.
[215] S. Hyman,et al. Addiction, Dopamine, and the Molecular Mechanisms of Memory , 2000, Neuron.
[216] K. Fuxe,et al. Bradykinin modulation of α 2-Adrenoceptors in the nucleus tractus solitarii of the rat. An in vitro autoradiographical study , 1995, Neuropharmacology.
[217] U. Ungerstedt,et al. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study , 2005, Journal of Neural Transmission / General Section JNT.
[218] B B Fredholm,et al. Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. , 1999, Biochemical pharmacology.
[219] P. Greengard,et al. Beyond the Dopamine Receptor: Review the DARPP-32/Protein Phosphatase-1 Cascade , 1999 .
[220] E. Keverne. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses , 1999, Brain Research Bulletin.
[221] K. Fuxe,et al. The C-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine D2 receptors. , 1993, European journal of pharmacology.
[222] B. O'dowd,et al. Oligomerization of μ- and δ-Opioid Receptors , 2000, The Journal of Biological Chemistry.
[223] R. Bahnson,et al. Pharmacological modulators of DNA-interactive antitumor drugs. , 1989, Trends in pharmacological sciences.
[224] K. Fuxe,et al. Aspects on the Integrative Capabilities of the Central Nervous System: Evidence for ‘Volume Transmission’ and its Possible Relevance for Receptor-Receptor Interactions , 1987 .
[225] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.
[226] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[227] Holger Husi,et al. Proteomics of the nervous system , 2001, Trends in Neurosciences.
[228] J. Schlessinger,et al. Signal transduction by allosteric receptor oligomerization. , 1988, Trends in biochemical sciences.
[229] K. Fuxe,et al. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes , 1994, Brain Research.
[230] P. Seeman,et al. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[231] S. Ferré,et al. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. , 2001, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[232] P. Worley,et al. Shank, a Novel Family of Postsynaptic Density Proteins that Binds to the NMDA Receptor/PSD-95/GKAP Complex and Cortactin , 1999, Neuron.
[233] H. Kase,et al. Inhibition by KF17837 of adenosine A2A receptor‐mediated modulation of striatal GABA and ACh release , 1994, British journal of pharmacology.
[234] K. Fuxe,et al. Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites , 1996, Neuroscience Letters.
[235] S. R. Nash,et al. Dopamine receptors: from structure to function. , 1998, Physiological reviews.
[236] K. Fuxe,et al. Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex , 1988, Neuroscience Letters.
[237] T. Robinson,et al. Amphetamine and cocaine induce different patterns of c‐fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context , 2001, The European journal of neuroscience.
[238] P. Svenningsson,et al. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. , 2000, Molecular pharmacology.
[239] H. Fibiger,et al. Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine , 1992, Neuroscience.
[240] S. Shiozaki,et al. KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. , 1994, European journal of pharmacology.
[241] K. Fuxe,et al. Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes. , 1993, European journal of pharmacology.
[242] Y C Kuo,et al. Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura. , 2000, Molecular pharmacology.
[243] S. Ferré. Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia , 1997, Psychopharmacology.
[244] P. Sexton,et al. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line. , 1997, Endocrinology.
[245] F. Ciruela,et al. Metabotropic Glutamate 1α and Adenosine A1 Receptors Assemble into Functionally Interacting Complexes* , 2001, The Journal of Biological Chemistry.
[246] B. Evers,et al. Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line , 1995, Molecular and cellular biology.
[247] E I Canela,et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[248] Michel Bouvier,et al. Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.
[249] D. Dorsa,et al. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[250] D. O. Hebb,et al. The organization of behavior , 1988 .
[251] Bruno Apolloni,et al. From Synapses to Rules: Discovering Symbolic Rules from Neural Processed Data , 2002 .
[252] J. Morrison,et al. Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.
[253] K. Fuxe,et al. Stimulation of adenosine A2 receptors induces catalepsy , 1991, Neuroscience Letters.
[254] U. Ungerstedt,et al. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. , 1991, European journal of pharmacology.
[255] Tony Pawson,et al. Protein modules and signalling networks , 1995, Nature.
[256] B. Fredholm,et al. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus , 1999, Neurochemistry International.
[257] F. F. Weight,et al. Single K+ channels activated by D2 dopamine receptors in acutely dissociated neurons from rat corpus striatum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[258] B. O'dowd,et al. Oligomerization of opioid receptors: generation of novel signaling units. , 2002, Current opinion in pharmacology.
[259] E. J. Simon,et al. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex. , 1990, The Journal of pharmacology and experimental therapeutics.
[260] U. Ungerstedt,et al. Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.
[261] J. Gutkind,et al. G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.
[262] S. Ögren,et al. Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated , 1994, Neuropsychopharmacology.
[263] J. Konieczny,et al. SCH 58261, an A2A adenosine receptor antagonist, counteracts parkinsonian‐like muscle rigidity in rats , 2001, Synapse.
[264] P. Greengard,et al. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons , 1998, Neuroscience.
[265] U. Ungerstedt,et al. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[266] S Avissar,et al. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[267] P. Wolynes,et al. The energy landscapes and motions of proteins. , 1991, Science.
[268] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[269] Yu Tian Wang,et al. Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors , 2000, Nature.
[270] M. Iyo,et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.
[271] K. Fuxe,et al. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia 1 Published on the World Wide Web on 12 January 1998. 1 , 1998, Brain Research Reviews.
[272] K. Fuxe,et al. Adenosine/dopamine receptor‐receptor interactions in the central nervous system , 2001 .
[273] K. Fuxe,et al. Neuropeptide Y and Central Cardiovascular Regulation , 1990 .
[274] T. Kenakin. Agonist-specific receptor conformations. , 1997, Trends in pharmacological sciences.
[275] K. Fuxe,et al. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[276] T. Hökfelt,et al. Aspects on receptor regulation and isoreceptor identification. , 1980, Medical biology.
[277] K. Fuxe,et al. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor‐mediated increase of NGFI‐A, c‐fos and jun‐B mRNA levels in the dopamine‐denervated striatum and dopamine D1 receptor‐mediated turning behaviour , 1999, The European journal of neuroscience.
[278] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[279] M. Ochi,et al. Systemic administration of adenosine A2A receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study , 2000, Neuroscience.
[280] J. Sweatt,et al. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory , 2001, Journal of neurochemistry.
[281] M. Caron,et al. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. , 1994, European journal of pharmacology.
[282] Diego Guidolin,et al. The Receptor Mosaic Hypothesis of the Engram: Possible Relevance of Boolean Network Modelling , 1996, Int. J. Neural Syst..
[283] B. Bloch,et al. Expression of the d3 dopamine receptor in peptidergic neurons of the nucleus accumbens: Comparison with the D1 and D2 dopamine receptors , 1996, Neuroscience.
[284] S. Schiffmann,et al. Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.
[285] T. Chase,et al. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism , 2000, Trends in Neurosciences.
[286] M. Morelli,et al. Involvement of Adenosine A2A Receptors in the Induction of C-Fos Expression by Clozapine and Haloperidol , 1999, Neuropsychopharmacology.
[287] K. Fuxe,et al. Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine‐denervated striatum , 2000, The European journal of neuroscience.
[288] Sergi Ferré,et al. Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.
[289] S. Vincent,et al. The effects of cysteamine on dopamine-mediated behaviors: Evidence for dopamine-somatostatin interactions in the striatum , 1986, Pharmacology Biochemistry and Behavior.
[290] T. Kenakin,et al. Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. , 1995, Trends in pharmacological sciences.
[291] U. Ungerstedt,et al. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia , 1994, Neuroscience.
[292] M. Delong,et al. Pathophysiologic basis of surgery for Parkinson's disease. , 2000, Neurology.
[293] T. Stone,et al. CNS Neurotransmitters and Neuromodulators: Dopamine , 1996 .
[294] J. Lacaille,et al. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. , 2001, Molecular pharmacology.
[295] L. Agnati,et al. Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum. , 2001, Advances in neurology.
[296] G. Paxinos. The Rat nervous system , 1985 .
[297] Neurology and Neurobiology , 1990 .
[298] F. Ciruela,et al. Ecto‐adenosine deaminase: An ecto‐enzyme and a costimulatory protein acting on a variety of cell surface receptors , 1998 .
[299] P. Leff. Receptor-based drug design , 1998 .
[300] S. Angers,et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[301] J. McGinty,et al. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. , 1997, The Journal of pharmacology and experimental therapeutics.
[302] M Morfis,et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.
[303] C. Nemeroff. The interaction of neurotensin with dopaminergic pathways in the central nervous system: Basic neurobiology and implications for the pathogenesis and treatment of schizophrenia , 1986, Psychoneuroendocrinology.
[304] M. Morelli,et al. Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas , 1997, Brain Research.
[305] P. Seeman,et al. A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization* , 1998, The Journal of Biological Chemistry.
[306] K. Fuxe,et al. Neurotensin Decreases the Affinity of Dopamine D2 Agonist Binding by a G Protein‐Independent Mechanism , 1991, Journal of neurochemistry.
[307] D. Engelman,et al. Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. , 1992, The Journal of biological chemistry.
[308] K. Fuxe,et al. Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons. , 1990, Annals of the New York Academy of Sciences.
[309] J. Linden,et al. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system , 1998, The Journal of comparative neurology.
[310] J. Holaday,et al. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. , 1988, The Journal of pharmacology and experimental therapeutics.
[311] P A Insel,et al. Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). , 2000, The Journal of pharmacology and experimental therapeutics.
[312] S. Ferré,et al. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. , 1998, European journal of pharmacology.
[313] F. Ciruela,et al. Adenosine Deaminase Interacts with A1 Adenosine Receptors in Pig Brain Cortical Membranes , 1996, Journal of neurochemistry.
[314] K. Fuxe,et al. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites. , 1983, Acta physiologica Scandinavica.
[315] Ted Abel,et al. Positive and negative regulatory mechanisms that mediate long-term memory storage 1 Published on the World Wide Web on 13 January 1998. 1 , 1998, Brain Research Reviews.
[316] E. Poleszak,et al. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats. , 2000, Polish Journal of Pharmacology.
[317] D. Engelman,et al. Specificity and promiscuity in membrane helix interactions , 1994, FEBS letters.
[318] C. Larsson,et al. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum. , 1997, Brain research. Molecular brain research.
[319] K. Fuxe,et al. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: Counteraction by a NTR1-like receptor antagonist , 2002, Neuroreport.
[320] M. Caron,et al. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. , 1997, Molecular pharmacology.
[321] M. Scarselli,et al. Pharmacological evidence of muscarinic receptor heterodimerization. , 2000, Pharmaceutica acta Helvetiae.
[322] C. Müller,et al. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. , 2001, Parkinsonism & related disorders.
[323] P. Sexton,et al. Characterization of Amylin and Calcitonin Receptor Binding in the Mouse α-Thyroid-Stimulating Hormone Thyrotroph Cell Line. , 1997, Endocrinology.
[324] J. Kemp,et al. Effect of metabotropic glutamate receptor activation on receptor-mediated cyclic AMP responses in primary cultures of rat striatal neurones , 1998, Brain Research.
[325] Luis Serrano,et al. Rational design of a GCN4-derived mimetic of interleukin-4 , 1999, Nature Structural Biology.
[326] Z. Bashir,et al. Cooperation between mglu receptors: a depressing mechanism? , 2002, Trends in Neurosciences.
[327] J. Fink,et al. Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway , 1995, Neuroscience.
[328] P. Worley,et al. Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins , 1999, Neuron.
[329] K. Fuxe,et al. Neurotensin reduces the affinity of D-2 dopamine receptors in rat striatal membranes. , 1987, Acta physiologica Scandinavica.
[330] O. Cordero,et al. Ecto-ADA in the development of the immune system. , 1998, Immunology today.
[331] S. Ferré,et al. Multiple intramembrane receptor-receptor interactions in the regulation of striatal dopamine D2 receptors. , 1999, Neuroreport.
[332] K. Fuxe,et al. Galanin/alpha2-receptor interactions in central cardiovascular control , 2000, Neuropharmacology.
[333] J. Joyce,et al. Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons , 1999, Neuropsychopharmacology.
[334] T. Gudermann,et al. Structural Implication for Receptor Oligomerization from Functional Reconstitution Studies of Mutant V2 Vasopressin Receptors* , 2000, The Journal of Biological Chemistry.
[335] P. Svenningsson,et al. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas , 1997, Neuroscience.
[336] Michel Bouvier,et al. A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.
[337] K. Fuxe,et al. Systemic oxytocin treatment modulates α2-adrenoceptors in telencephalic and diencephalic regions of the rat , 2000, Brain Research.
[338] M. Kwatra,et al. Regulation of Receptor Function by Protein Phosphorylation , 1990, Annals of the New York Academy of Sciences.
[339] T. Hunter,et al. Signaling—2000 and Beyond , 2000, Cell.
[340] B. O'dowd,et al. Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.
[341] S. Ferré,et al. Theophylline reverses haloperidol-induced catalepsy in the rat possible relevance to the pharmacological treatment of psychosis , 1988, Biological Psychiatry.
[342] Luigi F. Agnati,et al. Receptor‐receptor interactions in the central nervous system. A new integrative mechanism in synapses , 1985, Medicinal research reviews.
[343] K. Fuxe,et al. Angiotensin II reduces the affinity of [3H]para-aminoclonidine binding sites in membrane preparations from the rat dorsomedial medulla oblongata. , 1988, Acta physiologica Scandinavica.
[344] Koji Yamada,et al. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP , 1999, Psychopharmacology.
[345] K. Fuxe,et al. Heteromerization of Adenosine and Dopamine Receptor Subtypes: Relevance for Neuronal Integration in Normal and Pathological States , 2002 .
[346] P. Worley,et al. Homer: a link between neural activity and glutamate receptor function , 2000, Current Opinion in Neurobiology.
[347] U. Kumar,et al. The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization* , 1998, The Journal of Biological Chemistry.
[348] S. Grant,et al. Proteomics in Neuroscience: From Protein to Network , 2001, The Journal of Neuroscience.
[349] J. Vanderhaeghen,et al. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[350] P. Jenner,et al. Adenosine receptors and Parkinson's disease , 1999 .
[351] D. Standaert,et al. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A2A adenosine receptors , 2000, Neuroscience.
[352] L. Agnati,et al. Interactions among adenosine deaminase, adenosine A1 receptors and dopamine D1 receptors in stably cotransfected fibroblast cells and neurons , 2002, Neuroscience.
[353] M. Besson,et al. Glutamate Induces Phosphorylation of Elk-1 and CREB, Along with c-fos Activation, via an Extracellular Signal-Regulated Kinase-Dependent Pathway in Brain Slices , 1999, Molecular and Cellular Biology.
[354] K Fuxe,et al. Activation of Adensine A1 and A2A Receptors Modulates Dopamine D2 Receptor‐Induced Responses in Stably Transfected Human Neuroblastoma Cells , 2000, Journal of neurochemistry.
[355] Victor J. Quijano,et al. Prolactin Decreases Epidermal Growth Factor Receptor Kinase Activity via a Phosphorylation-dependent Mechanism* , 1998, The Journal of Biological Chemistry.
[356] T. Hökfelt,et al. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat , 1983, Neuroscience Letters.
[357] H. Nakata,et al. Heteromeric association creates a P2Y-like adenosine receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[358] B. Fredholm,et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[359] P. Greengard,et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[360] B. McEwen,et al. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[361] J. Mallol,et al. Adenosine Receptors in Myelin Fractions and Subtractions: The Effect of the Agonist (R)‐Phenylisopropyladenosine on Myelin Membrane Microviscosity , 1991, Journal of neurochemistry.
[362] A. Maggi,et al. beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system. , 1980, Science.
[363] D. Lovinger,et al. Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. , 2001, Journal of neurophysiology.
[364] A. Deutch,et al. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action , 1992, Molecular and Cellular Neuroscience.
[365] R. Boehm,et al. Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons , 2000, British journal of pharmacology.
[366] G. E. Alexander,et al. Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.
[367] E. M. Adler,et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.
[368] Henry A. Lester,et al. State-dependent cross-inhibition between transmitter-gated cation channels , 2000, Nature.
[369] Lakshmi A. Devi,et al. G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.
[370] R. Morris,et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein , 1998, Nature.
[371] U. Kumar,et al. Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.
[372] P. Jenner,et al. Adenosine A2A receptors modify motor function in MPTP‐treated common marmosets , 1998, Neuroreport.
[373] G Burnstock,et al. Nomenclature and Classification of Purinoceptors* , 2005 .
[374] S. Ferguson,et al. Mechanisms of metabotropic glutamate receptor desensitization: role in the patterning of effector enzyme activation , 2002, Neurochemistry International.
[375] P. Seeman,et al. Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.
[376] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[377] T. Hökfelt,et al. Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat. , 1983, Acta physiologica Scandinavica.
[378] Angus C Nairn,et al. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration 1 Published on the World Wide Web on 22 January 1998. 1 , 1998, Brain Research Reviews.
[379] U. Ungerstedt,et al. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.
[380] M. Morelli,et al. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6‐hydroxydopamine‐lesioned rats , 2001, Synapse.
[381] K. Rosenthal,et al. Stabilization of clathrin coated vesicles by amantadine, tromantadine and other hydrophobic amines , 1991, FEBS letters.
[382] M. Low,et al. The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice , 2001 .
[383] W. Hauber,et al. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. , 1997, European journal of pharmacology.
[384] P. Greengard,et al. Amplification of dopaminergic signaling by a positive feedback loop. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[385] K. Neve,et al. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. , 1994, The Journal of biological chemistry.
[386] Ronald W. Barrett,et al. Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.
[387] G. Chiara,et al. Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats , 1995, Neuroscience.
[388] P. Popoli,et al. Effects of SCH 58261, an Adenosine A2A Receptor Antagonist, on Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats: Lack of Tolerance after Chronic Caffeine Intake , 2000, Neuropsychopharmacology.
[389] G. Peterson,et al. Physical properties of the purified cardiac muscarinic acetylcholine receptor. , 1986, Biochemistry.
[390] T. Herdegen,et al. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins , 1998, Brain Research Reviews.
[391] U. Bhalla,et al. Complexity in biological signaling systems. , 1999, Science.
[392] R. Lefkowitz,et al. The β2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.
[393] E. Ongini,et al. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. , 1997, European journal of pharmacology.
[394] J. Tallman. Dimerization of G-Protein-Coupled Receptors: Implications for Drug Design and Signaling , 2000, Neuropsychopharmacology.
[395] R. Wise,et al. Rewarding Actions of Phencyclidine and Related Drugs in Nucleus Accumbens Shell and Frontal Cortex , 1996, The Journal of Neuroscience.
[396] Urs Gerber,et al. G-protein-independent signaling by G-protein-coupled receptors , 2000, Trends in Neurosciences.
[397] P. Sokoloff,et al. D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties* , 2001, The Journal of Biological Chemistry.
[398] J. Linden,et al. Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum , 2001, The Journal of comparative neurology.
[399] C Higgs,et al. Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.
[400] K. Fuxe,et al. On the Role of Neuropeptide Y in Information Handling in the Central Nervous System in Normal and Physiopathological States , 1990, Annals of the New York Academy of Sciences.
[401] Christopher A Reynolds,et al. Dimerization and Domain Swapping in G-Protein-Coupled Receptors: A Computational Study , 2000, Neuropsychopharmacology.
[402] K. Fuxe,et al. Oxytocin/Alpha2-Adrenoceptor Interactions in Feeding Responses , 2000, Neuroendocrinology.
[403] K. Fuxe,et al. Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections. , 1994, Neuroreport.
[404] Hiroshi Kase,et al. Rescue of Locomotor Impairment in Dopamine D2 Receptor-Deficient Mice by an Adenosine A2A Receptor Antagonist , 2000, The Journal of Neuroscience.
[405] John Q. Wang,et al. Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum , 2001, Neuroscience Letters.
[406] K. Fuxe,et al. Cholecystokinin Octapeptide In Vitro and Ex Vivo Strongly Modulates Striatal Dopamine D2 Receptors in Rat Forebrain Sections , 1995, The European journal of neuroscience.
[407] B. Fredholm. Purinoceptors in the nervous system. , 1995, Pharmacology & toxicology.
[408] K. Fuxe,et al. The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat. , 1996, Neuroreport.
[409] T. Hökfelt,et al. On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. , 1983, Acta physiologica Scandinavica.
[410] K. Fuxe,et al. Galanin-(1–15), but not galanin-(1–29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes , 1994, Brain Research.
[411] B. Fredholm,et al. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. , 2000, Molecular pharmacology.
[412] B. Fredholm,et al. A2a/D2 receptor interactions are not observed in COS-7 cells transiently transfected with dopamine D2 and adenosine A2a receptor cDNA. , 1994, Biochemical pharmacology.
[413] P. Jenner,et al. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. , 1997, Trends in pharmacological sciences.
[414] R. Weinberg,et al. The pathway to signal achievement , 1993, Nature.
[415] J P Changeux,et al. On the cooperativity of biological membranes. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[416] S. Nakanishi,et al. Activation of the extracellular signal‐regulated kinase 2 by metabotropic glutamate receptors , 1999, The European journal of neuroscience.
[417] U. Ungerstedt,et al. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. , 1991, European journal of pharmacology.
[418] S. Schiffmann,et al. Functional striatal hypodopaminergic activity in mice lacking adenosine A2A receptors , 2001, Journal of neurochemistry.
[419] J. Mallol,et al. Adenosine Deaminase and A1 Adenosine Receptors Internalize Together following Agonist-induced Receptor Desensitization* , 1998, The Journal of Biological Chemistry.
[420] P. Greengard,et al. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[421] Marc Montminy,et al. Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.
[422] F. Ciruela,et al. The Heat Shock Cognate Protein hsc73 Assembles with A1 Adenosine Receptors To Form Functional Modules in the Cell Membrane , 2000, Molecular and Cellular Biology.
[423] K. Blumer,et al. G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.
[424] R. Lefkowitz. The superfamily of heptahelical receptors , 2000, Nature Cell Biology.
[425] A. Charara,et al. GABAB and group I metabotropic glutamate receptors in the striatopallidal complex in primates , 2000, Journal of anatomy.
[426] G. Köhr,et al. Role of heteromer formation in GABAB receptor function. , 1999, Science.
[427] Alan Wise,et al. Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.
[428] R. Nicoll,et al. GABA-mediated biphasic inhibitory responses in hippocampus , 1979, Nature.
[429] A. Lajtha,et al. Diversity of interacting receptors , 1995 .
[430] H. Lother,et al. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration , 2000, Nature.
[431] U. Ungerstedt,et al. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[432] Robert J. Lefkowitz,et al. β-Adrenergic receptors: Evidence for negative cooperativity , 1975 .
[433] U. Ungerstedt,et al. On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat , 1983, Pharmacology Biochemistry and Behavior.
[434] A. Cochran. Protein-protein interfaces: mimics and inhibitors. , 2001, Current opinion in chemical biology.
[435] R. J. Boegman,et al. Involvement of adenosine and glutamate receptors in the induction of c‐fos in the striatum by haloperidol , 1996, Synapse.
[436] S. Nakanishi,et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.
[437] K. Deisseroth,et al. Activity-dependent CREB phosphorylation: Convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.